SG3 Management’s Immunomedics Inc IMMU Stock Holding History
Bought
Maintained
Sold
SG3 Management's IMMU Position: Q3 2020 in Review
SG3 Management sold out of Immunomedics Inc (IMMU) in Q3 2020, closing a stake of 27,500 shares — an estimated $1.39M sold.
SG3 Management first reported a position in IMMU in Q2 2020 and held it in 1 quarter. The position peaked at $975K in Q2 2020. 408 funds tracked by Wall St. Rank hold IMMU as of Q3 2020.
- SG3 Management reported no remaining Immunomedics Inc position as of Q3 2020 after selling out during the quarter.
- SG3 Management sold 27,500 Immunomedics Inc shares in Q3 2020, an estimated $1.39M.
- SG3 Management first reported a position in Immunomedics Inc in Q2 2020 and held it in 1 quarter.
- SG3 Management's Immunomedics Inc position peaked at $975K in Q2 2020.
- 408 funds tracked by Wall St. Rank held Immunomedics Inc as of Q3 2020.
Based on SG3 Management's 13F filing for Q3 2020, filed 13 Nov 2020.